J. Huting, PREDICTIVE VALUE OF MITRAL AND AORTIC-VALVE SCLEROSIS FOR SURVIVAL INEND-STAGE RENAL-DISEASE ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS, Nephron, 64(1), 1993, pp. 63-68
To determine whether mitral valve or anular sclerosis or calcification
(MC) is associated with reduced survival in patients with end-stage r
enal disease on continuous ambulatory peritoneal dialysis (CAPD), 53 C
APD patients were followed with echocardiography and Doppler echocardi
ography over 35 months. Both nonsurvivors and survivors with MC had hi
gher systolic blood pressure before CAPD and calcium-phosphorus produc
ts during CAPD treatment than patients without MC (p < 0.05). Serum ca
lcium and phosphorus concentrations, alkaline phosphatase and parathyr
oid hormone activities were higher in nonsurvivors and survivors with
than without MC (p > 0.05). Left ventricular end-diastolic and end-sys
tolic volumes were greater (p < 0.01), ejection fractions were smaller
(p < 0.05) in nonsurvivors with than without MC, but not in survivors
with versus without MC. Severe MC and grade Ill mitral valve regurgit
ation were more frequent in nonsurvivors than in survivors (p < 0.03).
No valvular stenoses were found. It is concluded that the development
of MC is favored by long-standing predialysis arterial hypertension a
nd by high calcium-phosphorus products during CAPD. Nonsurvivors with
MC are characterized by reduced systolic left ventricular function or
severe valvular lesions. A close cardionephrologic cooperation is nece
ssary to improve the survival of CAPD patients with these risk factors
.